Patrick Allison, PhD

Postdoctoral fellow at Michigan State University with Dr. Kurt Hankenson in the Laboratory for Comparative Orthopedic Research (LCOR). My research interests include the molecular regulation of angiogenesis, mesenchymal stem cell (MSC) recruitment, and MSC differentiation in long bone fracture healing.
Pharmacology and Toxicology
Pharmacology and Toxicology
Postdoctoral Research Associate, Michigan State University Lansing, MI
Dissertation Title: 
Src is Required for TGFB and Hyaluronan Induced Epicardial Cell Invasion, Differentiation, and Migration
Year Enrolled: 

B.S., Marine Science (2005)
University of Memphis, Memphis, Tennessee

Honors and Achievements: 
1. Yuma Friends of Arizona Health Sciences Center Young Investigator Research Award, 2011.
2. Human Genes and the Environment Research Training Program, 2011-13.
3. NIEHS Training in Environmental Toxicology of Human Diseases, 2013 (33).
1. Disruption in Canonical TGFβ-signaling in Coronary Progenitor Cells by Low Level Arsenic. Allison P, Huang T, Broka D, Parker P, Barnett JV, Camenisch TD. Toxicol. App. Pharmacol 2013 Oct 1;272(1):147-53.
2. Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233. Gurley SN, Abidi AH, Allison P, Guan P, Duntsch C, Robertson JH, Kosanke SD, Keir ST, Bigner DD, Elberger AJ, Moore BM 2nd. Neuro. Oncol. 2012 Nov;110(2):163-77.
3. Evaluation of novel vanilloid-based hemostatic agents in rats. Bhattacharjee H, Gurley SN, Allison PB, Zhang X, Moore BM 2nd. J. Trauma 2010 Mar;68(3):676-81.
4. Different residues mediate recognition of 1-O-oleyllysophosphatidic acid and rosiglitazone in the ligand binding domain of peroxisome proliferator-activated receptor gamma. Tsukahara T, Tsukahara R, Yasuda S, MarakovaN, Valentine WJ, Allison P, Yuan H, Baker DL, Li Z, Bittman R, Parrill A, Tigyi G. J Biol Chem 2006 Feb 10;281(6):3398-407.​
Career Type: